J Obes Metab Syndr 2020; 29(4): 241-243
Published online December 30, 2020 https://doi.org/10.7570/jomes20119
Copyright © Korean Society for the Study of Obesity.
Editor in Chief, Journal of Obesity & Metabolic Syndrome Department of Internal Medicine, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam, Korea
Department of Internal Medicine, Seoul National University Bundang Hospital, Seoul National University College of Medicine, 82 Gumi-ro 173beon-gil, Bundang-gu, Seongnam 13620, Korea
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
The prevalence of obesity is increasing worldwide.1,2 Upward trends in the prevalence rates of general and abdominal obesity have been observed among both sexes and nearly all age groups. The prevalence of such obesity patterns is higher among individuals with lower education and household income levels.3,4 In a survey performed in 11 countries with a total of 14,502 people with obesity and 2,785 healthcare providers, 68% of the former and 88% of the latter agreed that obesity is a disease. Half of all respondents were concerned about the impact of excess weight on health.5 However, there was a 6-year gap between the time people with obesity began struggling with their excess weight or obesity and when they first discussed this with healthcare providers. These data support a need to increase understanding of obesity and improve education concerning its physiological basis and clinical management. In South Korea, from 2009 to 2018, the prevalence of general and abdominal obesity increased to 35.7% and 23.8%, respectively.6 In a recent paper that investigated the perceptions, attitudes, behaviors, and barriers to effective obesity care in South Korea, we found that people with obesity in South Korea are motivated to lose weight and have expressed interest in healthcare providers being more active in their weight management.7 In this situation, a scientific platform to acquire and disseminate relevant knowledge about obesity is needed.
JOMES covers multidisciplinary aspects of obesity, particularly its epidemiology, including prevalence and characteristics, etiology, diagnosis, pathophysiology, and management and treatments such as lifestyle modifications and pharmacological therapies. I passionately believe that JOMES is helping to increase knowledge about obesity and is inspiring confidence in the dedication of physicians and scientists to dealing with it.
According to initial reports, old age, hypertension, preexisting cardiovascular diseases, and obesity are considered as significant risk factors for the acquisition of coronavirus disease 2019 (COVID-19).8 Thus, the severity of COVID-19 is strongly associated with diabetes mellitus.9 During the COVID-19 pandemic, the decrease in physical activity and an increase in sedentary time caused by quarantine measures such as social distancing and lockdowns should be a source of concern in terms of the increased risk of obesity. Access to a healthy diet for all is also an issue, and these factors in turn are likely to contribute to gaining weight and metabolic impairments.10 In this critical period, all scientific bodies should provide a list of recommended open sources for the promotion of physical activity/exercise and healthy eating to mitigate developing obesity. With JOMES editorial team members, we have published an important paper in JOMES on how to manage obesity during the COVID-19 pandemic,11 which has become one of the journal’s most widely read articles. Another most frequently read article is a paper on guidelines for managing obesity in Korea.12
JOMES was launched in 1992 and diverse studies on obesity were published under the title of the
JOMES was indexed in the Emerging Sources Citation Index (ESCI) in 2019, Scopus in 2019, and in PubMed and PubMed Central in 2019. We submitted the journal to be covered by Medline in 2019, but it was rejected because of the low volume of material. It was noted that the number of papers in JOMES was much lower than expected for a journal covering a major health issue for an entire country. In response to this comment, we have increased the number of papers in each issue to 12 or 13 from the first issue of 2020. The JOMES editorial team will reapply to Medline in 2022 and I hope that our journal will be listed there soon. Regarding the ESCI, I believe that it will be listed officially at SCI extended (SCIE) in 2021 and I trust that it will receive a high SCIE impact factor. Based on present calculations, the estimated SCIE impact factor for the journal will be 2.073.
Taken together, all of the articles of this journal are now included in the indexes of ESCI, Scopus, PubMed, PubMed Central, DOAJ, Ebsco, KCI, KoreaMed, KoMCI, Science Central, Crossref Metadata Search, and Google Scholar. The journal is also published on the official website of the
Our journal publishes Open Access articles distributed under the terms of the Creative Commons Attribution NonCommercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is cited properly. It can be accessed from PubMed Central (https://www.ncbi.nlm.nih.gov/pmc/journals/3611/). Importantly, the journal does not accept any commercial product advertisements under the present policy. Journal propagation is carried out through the journal’s website and distribution of an introduction pamphlet.
I commenced my duty as Editor in Chief of JOMES in 2017. In my first editorial, I promised that this new beginning with the journal would help maintain academic standards and take the lead in the development of the fields of obesity and metabolic syndrome.13 I have made efforts to improve the standards in terms of the editorial process and ethical guidelines under the Principles of Transparency and Best Practice in Scholarly Publishing, a Joint Statement by the Committee on Publication Ethics. I have also tried to improve the editorial process to ensure the timeliness of articles by simplifying the processes of reviewing, editing, and publishing. As noted, since 2017, JOMES has been indexed at many reputable official sites such as PubMed Central, in which I take pride. I believe that it will be accessed and referred to by many people more easily in the near future.
These advances were not possible without the help of our team of associate editors (Drs. Bo Kyung Koo, Ga Eun Nam, and Chang Hee Jung). I also thank Ms Ae Li Lee, the administrator of JOMES, for her invaluable assistance in editing manuscripts. Most of all, I would like to express my sincere thanks to Dr. Sun Huh, president of the Korean Association of Medical Journal Editors and the Korean Council of Science Editors, for his supportive guidance to the future direction of JOMES.14 With their efforts, JOMES will become one of the most respected and useful journals in this academic area.
In 2020, the JOMES website and submission system have been updated. The function of browsing through the articles has been enhanced with metric information for the journal such as the numbers of journal hits, downloads, and cross-reference citations. This upgrade is increasing the numbers of website visitors, content downloads, and manuscript submission. The JOMES editorial team has focused on improving the journal to become an even more rigorous platform to meet the expectations of clinicians, researchers, policy makers, and readers in the areas of obesity research and management. I firmly believe that our journal will soon be indexed at SCIE and Medline.
The author declares no conflict of interest.